Sentinel node biopsy in breast cancer: German Society for Senology defines quality standards;Wächterlymphknoten-Biopsie beim Mammakarzinom: Deutsche Gesellschaft für Senologie definiert Qualitätsstandards

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 8, 2004, Pages 387-390

  Kuhn T ^a   Kreienberg, R ^b  

^a Frauenklinik Gifhorn ^*  (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER CONTROL; GERMANY; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; REVIEW; STANDARD; TUMOR BIOPSY;

BREAST NEOPLASMS; FEMALE; GERMANY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PRACTICE GUIDELINES; SENTINEL LYMPH NODE BIOPSY; SOCIETIES, MEDICAL;

EID: 18544406523     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-819898     Document Type: Review

References (18)

1. Bergkvist L, Frisell J, Liljegren G, Celebioglu F, Damm S, Thörn M. Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 2001; 88: 1644-1648
2. Cserni G for the European Working Group for Breast Screening Pathology. Pathologic work-up of sentinel lymph nodes in breast cancer: Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003; 39: 1654-1667
3. Giuliano AE, Jones RC, Brennan M et al. Sentinel Lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-2350
4. Giuliano AE, Haigh PI, Brennan MB, Hansen NM et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel-node-negative breast cancer. J Clin Oncol 2000; 18: 2553-2559
5. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003; 21: 3357-3365
6. Heuser T, Rink T, Weller E, Fitz H, Zippel HH, Kreienberg R, Kuehn T. Impact of axillary nodal status on sentinel node mapping in breast cancer and ist relevance for tehnical proceeding. Breast Cancer Res Treat 2001; 67: 125-132
7. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg S, Shriver C, Felman S. The sentinel node in breast cancer: A multicenter validation study. New Engl J Med 1998; 339: 941-946
8. Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R. Long-term-morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 2000; 64: 275-286
9. Kühn T, Bembenek A, Büchels H, Decker T, Dunst J, Müllerleile U, Munz DL, Ostertag H, Sautter-Bihl ML, Schirrmeister H, Tulusan AH, Untch M, Winzer KJ, Wittekind C. Sentinel-Node-Biopsie beim Mammakarzinom. Interdisziplinär abgestimmter Konsensus der deutschen Gesellschaft für Senologie für eine qualitätsgesicherte Anwendung in der klinischen Routine. Onkologe 2003; 9: 1011-1016
10. Kuehn T, Vogl FD, Helms G, Pueckler S, Schirrmeister H, Strueber R, Koretz K, Kreienberg R. Sentinel Node-Biopsy is a reliable method for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J surg Oncol 2004; in press
11. McMasters KM, Tuttle TM, Carlson DJ, Brown CM et al. Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multiinstitutional practice when optimal technique is used. J Clin Oncol 2000; 18: 2560-2566
12. Roumen R, Kuijt GP, Liem IH, van Beek MWP. Treatment of 100 patients with sentinel-negative breast cancer without further axillary dissection. Br J Surg 2001; 88: 1639-1643
13. Sanidas EE, de Bree E, Tsiftis DD. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer. Am J Surg 2003; 185: 203-210
14. Schrenk P, Hatzi-Griesenhofer M, Shamiyeh A, Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001; 77: 165-170
15. Schwartz GF, Giuliano AE, Veronesi U (for the Consensus Conference Comittee). Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Piladelphia, Pennsylvania. Cancer 2002; 94: 2542-2551
16. Siegel BM, Mayzel KM, Love SM. Level I and II axillary dissection in the treatment of early stage breast cancer: an analysis of 259 consecutive patients. Arch Surg 1990; 125: 114-117
17. Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Carman CM, Molin MR, Yurko JE, Perry RR, Williams R. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001; 233: 51-59
18. Veronesi U, Paganelli G, Viale G, Path FR, Luini A, Zurrido S, Galimberti V, Intra M, Veronesi P, Robertson G, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553